|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 860 WINTER STREET |
Address2 |
|
City | WALTHAM |
State | MA |
Zip Code | 02451 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 23975-12
|
||||||||
|
6. House ID# 319670000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lois Dehls Cornell, Executive Vice President |
Date | 1/20/2022 9:05:29 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Childcare
Issues related to childcare - no specific bill
COVID-19 Pandemic & Pandemic Preparedness
H.R. 1319 - American Rescue Plan Act - including provisions on:
Vaccines
Testing, contact tracing, and mitigation
Hiring additional public health workers to support COVID-19 response
State and local funding
Health disparities and protecting vulnerable populations
Behavioral and mental health services
Expanding internet connectivity
Grant program for childcare
Food assistance programs
Small business loans/Paycheck Protection Program
Reducing health care premiums for low- and middle-income families by increasing the Affordable Care Acts (ACA) premium tax credits for 2021 and 2022
The continuation of employer-based health coverage by subsidizing COBRA coverage through the end of the fiscal year.
Health care subsidies for unemployed workers who are ineligible for COBRA.
Incentives and federal funding to expand Medicaid and CHIP eligibility
Allowing states to extend Medicaid and CHIP eligibility to women for 12 months postpartum.
General advocacy on COVID-19 relief and related policies:
Financial assistance for health care providers (Provider Relief Fund)
Issues related to personal protective equipment (PPE) and medical supplies
Issues related to pandemic preparedness
Support for resident physicians and medical students
Student loan forgiveness/debt relief
Federal Medicaid Match
State and local funding
Demographic data collection
Telemedicine/Telehealth
Mental and behavioral health
H.R. 2418 - Student Loan Forgiveness for Frontline Health Workers Act
Pandemic Production Act (PPA) (no bill number)
Gun Safety
S. 2325/H.R.4238 - Making America Safe and Secure (MASS) Act
Issues related to gun safety - no specific bill
Health Care
Issues related to health care/universal access to quality, equitable, affordable coverage - no specific bill
Issues related to mental and behavioral health care
Health Care Workforce
S. 54 - Strengthening America's Health Care Readiness Act
S. 834/ H.R.2256 - Resident Physician Shortage Reduction Act of 2021
S.610/ H.R.1667 - Dr. Lorna Breen Health Care Provider Protection Act
S.3244/ H.R.5602 - BIO Preparedness Workforce Act of 2021
Issues related to the affordability of medical education and federal loan programs - no specific bill
Issues related to scope of practice - no specific bill
Issues related to the Department of Veterans Affairs Federal Supremacy Project
Immigration
Issues related to Immigration - no specific bill
S. 1024/H.R. 2255 - Healthcare Workforce Resilience Act
Infrastructure
H.R.3684 - Infrastructure Investment and Jobs Act
Issues related to broadband access
Issues related to the Build Back Better framework
Interoperability/ONC
Issues related to interoperability and information blocking - no specific bill
Nutrition
H.R.5370 - Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2021
Issues related to nutrition and food security
Racial Justice/Health Equity
S. 162/H.R. 666 - Anti-Racism in Public Health Act of 2021
Issues related to racial justice/health care equity
Maternal Health
S. 411/ H.R. 3407 - Mothers and Offspring Mortality and Morbidity Awareness (MOMMA's) Act
Medical Education
Issues related to the affordability of medical education - no specific bill
Medicare/Medicaid
S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
Issues related to Medicare physician payment
H.R. 1587/ S. 1731 - Medicare Audiologist Access and Services Act of 2021
Issues related to Medicare/Medicaid - no specific bill
Issues related to prior authorization and administrative simplification - no specific bill
H.R.3173 - Improving Seniors Timely Access to Care Act of 2021
Issues related to Medicare Advantage risk adjustment
Opioids/ Substance Use Disorder
H.R.6311/ S.3418 - Comprehensive Addiction Resources Emergency (CARE) Act
S. 2354 - Safer Prescribing of Controlled Substances Act
H.R.1026 / S.2353 - LABEL Opioids Act of 2021
Issues related to opioids and substance use disorder - no specific bill
Prescription Drug Pricing
Issues related to prescription drug pricing - no specific bill
Publications
Open access to information based on publicly funded research
Issues related to scholarly and scientific publishing and public access
S.1260 - United States Innovation and Competition Act of 2021
Surprise Billing
Issues related to surprise billing - no specific bill
Issues related to the implementation of the No Surprises Act
Telehealth
Issues related to telehealth
Issues related to telebehavioral health access
Issues related to physician licensing
S. 368/H.R. 1332 - Telehealth Modernization Act
Vaccines
Issues related to vaccines - no specific bill
Regulatory
Medicare Program; CY 2022 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Provider Enrollment Regulation Updates; Provider and Supplier Prepayment and Post-payment Medical Review Requirements.
Interim Final Rule (IFR) - Requirements Related to Surprise Billing; Part I
IFR - Requirements Related to Surprise Billing; Part II
These are regulations implementing provisions of Title I (No Surprises Act) of Division BB of the Consolidated Appropriations Act, 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs - Dept of (VA), White House Office, Labor - Dept of (DOL), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Childcare
Issues related to childcare - no specific bill
COVID-19 Pandemic & Pandemic Preparedness
H.R. 1319 - American Rescue Plan Act - including provisions on:
Vaccines
Testing, contact tracing, and mitigation
Hiring additional public health workers to support COVID-19 response
State and local funding
Health disparities and protecting vulnerable populations
Behavioral and mental health services
Expanding internet connectivity
Grant program for childcare
Food assistance programs
Small business loans/Paycheck Protection Program
Reducing health care premiums for low- and middle-income families by increasing the Affordable Care Acts (ACA) premium tax credits for 2021 and 2022
The continuation of employer-based health coverage by subsidizing COBRA coverage through the end of the fiscal year.
Health care subsidies for unemployed workers who are ineligible for COBRA.
Incentives and federal funding to expand Medicaid and CHIP eligibility
Allowing states to extend Medicaid and CHIP eligibility to women for 12 months postpartum.
General advocacy on COVID-19 relief and related policies:
Financial assistance for health care providers (Provider Relief Fund)
Issues related to personal protective equipment (PPE) and medical supplies
Issues related to pandemic preparedness
Support for resident physicians and medical students
Student loan forgiveness/debt relief
Federal Medicaid Match
State and local funding
Demographic data collection
Telemedicine/Telehealth
Mental and behavioral health
H.R. 2418 - Student Loan Forgiveness for Frontline Health Workers Act
Pandemic Production Act (PPA) (no bill number)
Gun Safety
S. 2325/H.R.4238 - Making America Safe and Secure (MASS) Act
Issues related to gun safety - no specific bill
Health Care
Issues related to health care/universal access to quality, equitable, affordable coverage - no specific bill
Issues related to mental and behavioral health care
Health Care Workforce
S. 54 - Strengthening America's Health Care Readiness Act
S. 834/ H.R.2256 - Resident Physician Shortage Reduction Act of 2021
S.610/ H.R.1667 - Dr. Lorna Breen Health Care Provider Protection Act
S.3244/ H.R.5602 - BIO Preparedness Workforce Act of 2021
Issues related to the affordability of medical education and federal loan programs - no specific bill
Issues related to scope of practice - no specific bill
Issues related to the Department of Veterans Affairs Federal Supremacy Project
Immigration
Issues related to Immigration - no specific bill
S. 1024/H.R. 2255 - Healthcare Workforce Resilience Act
Infrastructure
H.R.3684 - Infrastructure Investment and Jobs Act
Issues related to broadband access
Issues related to the Build Back Better framework
Interoperability/ONC
Issues related to interoperability and information blocking - no specific bill
Nutrition
H.R.5370 - Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2021
Issues related to nutrition and food security
Racial Justice/Health Equity
S. 162/H.R. 666 - Anti-Racism in Public Health Act of 2021
Issues related to racial justice/health care equity
Maternal Health
S. 411/ H.R. 3407 - Mothers and Offspring Mortality and Morbidity Awareness (MOMMA's) Act
Medical Education
Issues related to the affordability of medical education - no specific bill
Medicare/Medicaid
S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
Issues related to Medicare physician payment
H.R. 1587/ S. 1731 - Medicare Audiologist Access and Services Act of 2021
Issues related to Medicare/Medicaid - no specific bill
Issues related to prior authorization and administrative simplification - no specific bill
H.R.3173 - Improving Seniors Timely Access to Care Act of 2021
Issues related to Medicare Advantage risk adjustment
Opioids/ Substance Use Disorder
H.R.6311/ S.3418 - Comprehensive Addiction Resources Emergency (CARE) Act
S. 2354 - Safer Prescribing of Controlled Substances Act
H.R.1026 / S.2353 - LABEL Opioids Act of 2021
Issues related to opioids and substance use disorder - no specific bill
Prescription Drug Pricing
Issues related to prescription drug pricing - no specific bill
Publications
Open access to information based on publicly funded research
Issues related to scholarly and scientific publishing and public access
S.1260 - United States Innovation and Competition Act of 2021
Surprise Billing
Issues related to surprise billing - no specific bill
Issues related to the implementation of the No Surprises Act
Telehealth
Issues related to telehealth
Issues related to telebehavioral health access
Issues related to physician licensing
S. 368/H.R. 1332 - Telehealth Modernization Act
Vaccines
Issues related to vaccines - no specific bill
Regulatory
Medicare Program; CY 2022 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Provider Enrollment Regulation Updates; Provider and Supplier Prepayment and Post-payment Medical Review Requirements.
Interim Final Rule (IFR) - Requirements Related to Surprise Billing; Part I
IFR - Requirements Related to Surprise Billing; Part II
These are regulations implementing provisions of Title I (No Surprises Act) of Division BB of the Consolidated Appropriations Act, 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs - Dept of (VA), White House Office, Labor - Dept of (DOL), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Publications
Open access to information based on publicly funded research
Issues related to scholarly and scientific publishing and public access
S.1260 - United States Innovation and Competition Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Issues related to Immigration - no specific bill
S. 1024/H.R. 2255 Healthcare Workforce Resilience Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Medical Education
Issues related to the affordability of medical education - no specific bill
H.R. 2418 Student Loan Forgiveness for Frontline Health Workers Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Prescription Drug Pricing
Issues related to prescription drug pricing - no specific bill
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Opioids/ Substance Use Disorder
Comprehensive Addiction Resources Emergency (CARE) Act (no bill number)
S. 2354 Safer Prescribing of Controlled Substances Act
H.R.1026 / S.2353 LABEL Opioids Act of 2021
Issues related to opioids and substance use disorder - no specific bill
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Gun Safety
S. 2325/H.R.4238 - Making America Safe and Secure (MASS) Act
Issues related to gun safety - no specific bill
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Surprise Billing
Issues related to surprise billing - no specific bill
Issues related to the implementation of the No Surprises Act
Regulatory
Interim Final Rule (IFR) - Requirements Related to Surprise Billing; Part I
IFR - Requirements Related to Surprise Billing; Part II
These are regulations implementing provisions of Title I (No Surprises Act) of Division BB of the Consolidated Appropriations Act, 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandria |
Icenhower |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |